The familial unconjugated hyperbilirubinemias

Seminars in Liver Disease

Volumn 14, Issue 4, 1994, Pages 356-385

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CRIGLER NAJJAR SYNDROME; GENETICS; GILBERT DISEASE; HUMAN; HYPERBILIRUBINEMIA; METABOLISM; PATHOLOGY; PROGNOSIS; REVIEW;

CRIGLER-NAJJAR SYNDROME; GILBERT DISEASE; HUMAN; HYPERBILIRUBINEMIA, HEREDITARY; PROGNOSIS;

EID: 0028540958     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007328     Document Type: Article

References (290)

1. Crigler JF, Najjar VA: Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 10:169-80. 1952.
2. Blaschke TF, Berk PD, Scharschmidt BF, Guyther JR, Vergalla J, Waggoner JG: Crigler-Najjar syndrome: an unusual course with development of neurologic damage at age eighteen. Pediatr Res 8:573-90, 1974.
3. Childs B, Najjar VA: Familial nonhemolytic jaundice with kernicterus: a report of two cases without neurologic damage. Pediatrics 18:369-77, 1956.
4. Bartolozzi G, Ciampolini M, Salti R, Verrotti M: La malattia di Crigler-Najjar: presentazione di un case. Minerva Pediatr 21:2393-3406, 1969.
5. Huang PWH, Rozdilsky B, Gerrard JW, Goluboff N, Holman CH: Crigler-Najjar syndrome in four of five siblings with postmortem findings in one. Arch Pathol 90:536-42, 1970.
6. Kaplan M, Straus P, Bijaoui G, Bensadoun M: Maladie de Crigler et Najjar: etude clinique et biologique d'une observation. Aspect du tissue hepatique au microscope electronique. Ann Pediatr 13:583-96, 1966.
7. Blumenschein SD, Kallen RJ, Storey B, Natzschka C, Odell GB, Childs B: Familial nonhemolytic jaundice with late onset of neurological damage. Pediatrics 786-92, 1968.
8. Berk PD, Martin JF, Blaschke TF, Scharschmidt BF, Plotz PH: Unconjugated hyperbilirubinemia: physiologic evaluation and experimental approaches to therapy. Ann Intern Med 82:552-70, 1975.
9. Berk PD, Scharschmidt BF, Waggoner JG, White SC: The effect of repeated phlebotomy on bilirubin turnover, bilirubin clearance and unconjugated hyperbilirubinemia in the CriglerNajjar syndrome and the jaundiced Gunn rat: application of computers to experimental design. Clin Sci Mol Med 50:333-48, 1976.
10. Wolkoff AW, Roy Chowdhury J. Gartner LA, et al: Crigler-Najjar syndrome (type I) in an adult male. Gastroenterology 76:840-8, 1979.
11. Gardner WA, Konigsmark B: Familial nonhemolytic jaundice: bilirubinosis and encephalopathy. Pediatrics 43:365-76, 1969.
12. Pett S, Mowat AP: Crigler-Najjar syndrome types I and II. Clinical experience - King's College Hospital 1972-1978. Phenobarbitone, phototherapy and liver transplantation. Mol Aspects Med 9:473-82, 1987.
13. Solomon G, Labar D, Galbraith RA, Schaefer J, Kappas A: Neurophysiological abnormalities in adolescents with type I Crigler-Najjar syndrome. Electroencephalogr Clin Neurophysiol 76:473-5, 1990.
14. Berk PD, Jones EA, Howe RB, Berlin NI: Disorders of bilirubin metabolism. In: Bondy PK, Rosenberg L (eds). Metabolic control and disease. 8th ed. Philadelphia: WB Saunders, 1009-88, 1979.
15. Roy Chowdhury J, Arias IM: Disorders of bilirubin conjugation. In: Ostrow JD (ed). Bile pigments and jaundice. New York: Marcel Dekker, 317-32, 1986.
16. 14-bilirubin in congenital nonhemolytic jaundice. J Clin Invest 42:1720-34, 1963.
17. Bloomer JR, Berk PD, Howe RB, Berlin NI: Bilirubin metabolism in congenital nonhemolytic jaundice. Pediatr Res 5:256-64, 1971.
18. Arias IM, Gartner LM, Cohen M, Ben-Ezzer J, Levi AJ: Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency: evidence for genetic heterogeneity. Trans Assoc Am Physicians 81:66-75, 1968.
19. DeBrito T, Borges MA, DaSilva LC: Electron microscopy of the liver in nonhemolytic acholuric jaundice with kernicterus (Crigler-Najjar) and in idiopathic conjugated hyperbilirubinemia (Rotor). Gastroenterologia 106:325-35, 1966.
20. Minio-Paluello F, Gautier A, Magnenat P: L'ultrastructure du foie humain dans un cas de Crigler-Najjar. Acta Hepatosplenol 15:65-71, 1968.
21. Fevery J, Blanckaert N, Heirwegh KPM, Preaux A-M, Berthelot P: Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar syndrome. J Clin Invest 60:970-9, 1977.
22. Muraca M, Blanckaert N: Gilbert's syndrome and Crigler-Najjar disease exhibit characteristic serum bilirubin patterns. Hepatology 2:749, 1982.
23. Arias IM, Gartner LM, Cohen M, Ben-Ezzer J, Levi AJ: Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency: clinical, biochemical, pharmacologic, and genetic evidence for heterogeneity. Am J Med 47:395-409, 1969.
24. Sinaasappel M, Jansen PLM: The differential diagnosis of Crigler-Najjar disease, types 1 and 2, by bile pigment analysis. Gastroenterology 100:783-9, 1991.
25. Blanckaert N, Kabra PM, Farina FA, et al: Measurement of bilirubin and its monoconjugates and diconjugates in human serum by alkaline methanolysis and high-performance liquid chromatography. J Lab Clin Med 96:198-212, 1980.
26. 14C-bilirubin in congenital nonhaemolytic hyperbilirubinemia. Clin Sci 27:163-70, 1964.
27. Szabo L, Kovacs Z, Ebrey PB: Crigler-Najjar's syndrome. Acta Paediatr Hung 3:49-70, 1962.
28. Whitington GL: Congenital nonhemolytic icterus with damage to the central nervous system. Report of a case in a Negro child. Pediatrics 25:437-40, 1960.
29. Gordon ER, Shaffer EA, Sass-Kortsak A: Bilirubin secretion and conjugation in the Crigler-Najjar syndrome type II. Gastroenterology 70:761-5, 1976.
30. Gunn CH: Hereditary acholuric jaundice in a new mutant strain of rats. J Hered 29:137-9, 1938.
31. Axelrod J, Schmid R, Hammaker L: A biochemical lesion in congenital, non-obstructive, non-haemolytic jaundice. Nature 180:1426-7, 1957.
32. Blanckaert N, Fevery J, Heirwegh KPM, Compernolle F: Characterization of the major diazo-positive pigments in bile of homozygous Gunn rats. Biochem J 164:237-49, 1977.
33. Childs B, Sidbury JB, Migeon CJ: Glucuronic acid conjugation by patients with familial nonhemolytic jaundice and their relatives. Pediatrics 23:903-13, 1959.
34. Szabo L, Ebrey P: Studies on the inheritance of Crigler-Najjar syndrome by the menthol test. Acta Paediatr Hung 4:153-8, 1963.
35. Jansen FH, Malvax P, Heirwegh KPM, Devriendt A: Congenital non-hemolytic jaundice: Crigler Najjar syndrome. Biol Neonate 14:53-61, 1969.
36. Arias IM: Ethereal and N-linked glucuronide formation by normal and Gunn rats in vitro and in vivo. Biochem Biophys Res Commun 8:81-4, 1961.
37. Fevery J, Leroy P, Heirwegh KPM: Enzymatic transfer of glucose and xylose from uridine diphosphate glucose and uridine diphosphate xylose to bilirubin by untreated and digitonin-activated preparations from rat liver. Biochem J 129:619-33, 1972.
38. Blanckaert N, Heirwegh KPM, Zaman Z: Comparison of the biliary excretion of the four isomers of bilirubin-IX in Wistar and homozygous Gunn rats. Biochem J 164:229-36, 1977.
39. Lester R, Klein PD: Bile pigment excretion: a comparison of the biliary excretion of bilirubin and bilirubin derivatives. J Clin Invest 45:1839-46, 1966.
40. Nakata D, Zakim D, Vessey DA: Defective function of microsomal UDP-glucuronyltransferase in Gunn rats. Proc Natl Acad Sci USA 73:289-92, 1967.
41. Jansen PLM, Roy Chowdhury J, Fischberg EB, Arias IM: Enzymatic conversion of bilirubin monoglucuronide to diglucuronide by liver plasma membranes. J Biol Chem 252:2710-16. 1977.
42. Roy Chowdhury J, Roy Chowdhury N, Arias IM: Purification and partial characterization of rat liver bilirubin glucuronoside glucuronosyl transferase. J Biol Chem 254:8336-9, 1979.
43. Roy Chowdhury J, Fischberg EB, Daniller A, Jansen PLM, Arias IM: Hepatic conversion of bilirubin monoglucuronide to bilirubin diglucuronide in uridine diphosphate glucuronosyl transferase deficient man and rat by bilirubin glucuronide glucuronosyl transferase. J Clin Invest 21:191-6, 1978.
44. Sieg A, Van Hees GP, Heirwegh KPM: Uridine diphosphateglucuronic acid-independent conversion of bilirubin monoglucuronides to diglucuronides in the presence of plasma membranes from rat liver is nonenzymic. J Clin Invest 69:347-57, 1982.
45. McDonagh AF, Palma LA, Lightner DA: Blue light and bilirubin excretion. Science 208:145-51, 1980.
46. Stoll MS, Zenone EA, Ostrow JD, Zarembo JE: Preparation and properties of bilirubin photoisomers. Biochem J 183:139-46, 1979.
47. Berry CS, Zarembo JE, Ostrow JD: Evidence of conversion of bilirubin to dihydroxyl derivatives in the Gunn rat. Biochem Biophys Res Commun 49:1366-75, 1972.
48. Tiribelli C, Ostrow JD: New concepts in bilirubin chemistry, transport and metabolism: report of the Second International Bilirubin Workshop, April II, 1992, Trieste, Italy. Hepatology 17:715-36, 1993.
49. Berk PD, Javitt N: Hyperbilirubinemia: physiologic evaluation and experimental approaches to therapy. Ann Intern Med 82:552-70, 1975.
50. Malloy HT, Lowwenstein L: Hereditary jaundice in the rat. Can Med Assoc J 42:122-5, 1940.
51. Carbone JV, Grodsky GM: Constitutional non-hemolytic hyperbilirubinemia in the rat: defect of bilirubin conjugation. Proc Soc Exp Biol Med 94:461-3, 1957.
52. Schmid R, Axelrod J, Hammaker L, Swarm R: Congenital jaundice in rats due to a defect in glucuronide formation. J Clin Invest 37:1123-30, 1958.
53. Johnson L, Sarmiento F, Blanc WA, Day R: Kernicterus in rats with an inherited deficiency of glucuronyl transferase. AMA J Dis Child 97:591-608, 1958.
54. Novikoff AB, Esner E: The liver cell. Am J Med 29:102-31, 1960.
55. Cornelius CE, Arias IM: Animal model of human disease: hereditary nonhemolytic unconjugated hyperbilirubinemia in Gunn rats. Am J Pathol 69:369-72, 1972.
56. Roy Chowdhury J, van Es HHG, Roy Chowdhury N: Gunn rat: an animal model for deficiency of bilirubin conjugation. In: Tavoloni N, Berk PD (eds). Hepatic transport and bile secretion: Physiology and pathophysiology. New York: Raven Press, 713-9, 1993.
57. Schmid R, Axelrod J, Hammaker L, Rosenthal IM: Congenital defects in bilirubin metabolism. J Clin Invest 36:927, 1957.
58. Aitio A, Parkki MG, Marniemi J: Different effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on glucuronide conjugation of various aglycones: studies in Wistar and Gunn rats. Toxicol Appl Pharmacol 47:55-60, 1979.
59. Puukka R, Tanner P, Honninen O: Enzymes of the glucuronic acid pathway in Wistar and Gunn rats and their heterozygotes. Biochem Genet 9:343-9, 1973.
60. de Morais SMF, Wells PG: Enhanced acetaminophen toxicity in rats with bilirubin glucuronyl transferase deficiency. Hepatology 10:163-7, 1989.
61. Watkins JB, Klaasen CD: Development of UDP-glucuronosyltransferase activities in Gunn, heterozygous, and Wistar rat livers by pregnenolone-16α-carbonitrile. Drug Metab Dispos 13:186-91, 1985.
62. Gorsky JP, Kasper CB: Purification and properties of microsomal UDP-glucuronosyltransferase from rat liver. J Biol Chem 252:1336-43, 1977.
63. Erickson RH, Zakim D, Vessey DA: Preparation and properties of a phospholipid-free form of microsomal UDP-glucuronyltransferase. Biochemistry 17:3706-11, 1978.
64. Bock KW, Josting D, Lillenblum W, Pfeil H: Purification of rat-liver microsomal UDP-glucuronyl transferase. Separation of two enzyme forms inducible by 3-methylcholanthrene or phenobarbital. Eur J Biochem 98:19-26, 1979.
65. Zakim D, Goldenberg J, Vesey DA: Influence of membrane lipids on the regulatory properties of UDP-glucuronyltransferase. Eur J Biochem 38:59-63, 1973.
66. Burchell B, Blanckaert N: Bilirubin mono- and diglucuronide formation by purified rat liver microsomal bilirubin UDP glucuronosyltransferase. Biochem J 223:461-5, 1984.
67. Falany CN, Tephly TR: Separation, purification and characterization of three isoenzymes of UDP-glucuronyltransferase from rat liver microsomes. Arch Biochem Biophys 227:248-58, 1984.
68. Kirkpatrick RB, Falany CN, Tephly TR: Glucuronidation of bile acids by rat liver 3-OH androgen UDP-glucuronyltransferase. J Biol Chem 259:6176-80, 1984.
69. Von Meyerinck L, Coffman BL, Green MD, Kirkpatrick RB, Schmoldt A, Tephly TR: Separation, purification and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity. Drug Metab Dispos 13:700-4, 1985.
70. Puig JF, Tephly TR: Isolation and purification of rat liver morphine UDP-glucuronosyltransferase. Mol Pharmacol 30:558-65, 1986.
71. Roy Chowdhury J, Roy Chowdhury N, Falany CN, Tephly TR, Arias IM: Isolation and characterization of multiple forms of rat liver UDP-glucuronate glucuronosyltransferase. Biochem J 233:827-37, 1986.
72. Abe N, Abe E, Yuasa A: Purification and properties of 5-hydroxytryptamine UDP-glucuronyltransferase from rat liver microsomes. J Biochem 104:421-6, 1988.
73. Roy Chowdhury N, Lederstein M, Lahiri P, et al: Isolation and characterization of a new rat liver bilirubin-UDP-glucuronosyltransferase that also mediates the glucuronidation of morphine. Hepatology 14:149A, 1991.
74. Burchell B: Molecular biology of the uridine diphosphate glucuronosyl transferases. In: Tavoloni N, Berk PD (eds). Hepatic transport and bile secretion: Physiology and pathophysiology. New York: Raven Press, 489-99, 1993.
75. Scragg I, Celier C, Burchell B: Congenital jaundice in rats due to the absence of hepatic bilirubin UDP-glucuronyltransferase enzyme protein. FEBS Lett 183:37-42, 1985.
76. Roy Chowdhury J, Novikoff PM, Roy Chowdhury N, Novikoff AB: Distribution of UDP-glucuronosyltransferase in rat tissue. Proc Natl Acad Sci USA 82:2990-4, 1985.
77. Roy Chowdhury N, Gross F, Moscioni AD, Kram M, Arias IM: Isolation of multiple normal and functionally defective forms of uridine diphosphate-glucuronosyltransferase from inbred Gunn rats. J Clin Invest 79:327-34, 1987.
78. Coughtrie MWH, Burchell B, Shepherd IM, Bend JR: Defective induction of phenol glucuronidation by 3-methylcholanthrene in Gunn rats is due to the absence of a specific UDP-glucuronosyltransferase isoenzyme. Mol Pharmacol 31:585-91, 1987.
79. Peters WHM, Allebes WA, Jansen PLM, Poels LG, Capel PGA: Characterization and tissue specificity of a monoclonal antibody against human uridine-5'-diphosphate glucuronyltransferase. Gastroenterology 93:162-9, 1987.
80. Peters WHM, Jansen PLM: Immunocharacterization of UDP-glucuronyl-transferase isoenzymes in human liver, intestine and kidney. Biochem Pharmacol 37:564-7, 1987.
81. van Es HHG, Goldhoorn BG, Paul-Abrahamse M, Oude Elferink R, Jansen PLM: Immunochemical analysis of uridine diphosphateglucuronosyltransferase in four patients with the Crigler-Najjar syndrome type I. J Clin Invest 85:1199-205, 1990.
82. van Es HHG: Molecular studies on UDP-glucuronosyltransferase in the Crigler-Najjar syndrome and related disorders. Amsterdam: University of Amsterdam, 1990. Dissertation.
83. Vainio H, Heitanen E: Induction deficiency of the microsomal UDP-glucuronosyltransferase by 3-methylcholanthrene in Gunn rats. Biochim Biophys Acta 362:92-9, 1974.
84. Iyanagi T, Haniu M, Sogawa K, et al: Cloning and characterization of a cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase. J Biol Chem 261: 15607-14, 1986.
85. Harding D, Jackson M, Corser R, Burchell B: Phenol UDPglucuronosyltransferase deficiency in Gunn rats: mRNA levels are considerably reduced. Biochem Pharmacol 38:1013-7, 1989.
86. Iyanagi T, Watanabe T, Uchiyama Y: The 3-methylcholanthrene-inducible UDP-glucuronosyltransferase deficiency in the hyperbilirubinemic rat (Gunn rat) is caused by a - 1 frameshift mutation. J Biol Chem 264:21302-7, 1989.
87. El Awady M, Roy Chowdhury J, Kesari K, et al: Mechanism of the lack of induction of UDP-glucuronosyltransferase activity in Gunn rats by 3-methylcholanthrene: identification of a truncated enzyme. J Biol Chem 265:10752-8, 1990.
88. Sato H, Koiwai O, Tanabe K, Kashiwamata S: Isolation and sequencing of rat liver bilirubin UDP-glucuronosyltransferase cDNA: possible alternative splicing of a common primary transcript. Biochem Biophys Res Commun 169:260-4, 1990.
89. Sato H, Aino S, Kashiwamata S, Koiwai O: Genetic defect of bilirubin UDP-glucuronosyltransferase in the hyperbilirubinemic Gunn rat. Biochem Biophys Res Commun 177:1161-4, 1991.
90. Iyanagi T: Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat (Gunn rat). J Biol Chem 266:24048-52, 1991.
91. Roy Chowdhury J, Huang T, Kesari K, Lederstien M, Arias IM: Molecular basis for the lack of bilirubin-specific and 3-methylcholanthrene-inducible UDP-glucuronosyltransferase activities in Gunn rats. The two isoforms are encoded by distinct mRNA species that share an identical single base deletion. J Biol Chem 266:18294-8, 1991.
92. Jansen PLM, Mulder GJ, Burchell B, Bock KW: New developments in glucuronidation research: report of a workshop on "Glucuronidation, Its Role in Health and Disease". Hepatology 15:532-44, 1992.
93. Huang T-J, Roy Chowdhury J, Lahiri P, et al: Prenatal diagnosis of bilirubin-UDP-glucuronosyltransferase deficiency in rats by genomic DNA analysis. Hepatology 16:756-62, 1992.
94. Onishi S, Kawade N, Itoh S, Sugiyama S: Postnatal development of uridine diphosphate glucuronosyltransferase activity towards bilirubin and 2-aminophenol in human liver. Biochem J 184:705-7, 1979.
95. Burchell B, Coughtrie MWH, Jackson MR, Shepherd S, Harding D, Hume R: Genetic deficiency of bilirubin glucuronidation in rats and humans. Mol Aspects Med 9:429-55, 1987.
96. Robertson KJ, Clark D, Sutherland L, Wooster R, Coughtrie MWH, Burchell B: Investigations of the molecular basis of the genetic deficiency of UDP-glucuronosyltransferase in Crigler-Najjar syndrome. J Inherited Metab Dis 14:563-79, 1991.
97. Owens IS, Ritter JK: The novel bilirubin/phenol UDP-glucuronosyltransferase UGT1 gene locus: implications for multiple nonhemolytic familial hyperbilirubinemia phenotypes. Pharmacogenetics 2:93-108, 1992.
98. Bosma PJ, Roy Chowdhury N, Goldhoorn BG, et al: Sequence of exons and flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome type I. Hepatology 15:941-7, 1992.
99. Bosma PJ, Roy Chowdhury J, Huang T-J, et al: Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I. FASEB J 6:2859-63, 1992.
100. Ritter JK, Yeatman M, Ferreira P, Owens IS: Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient. J Clin Invest 90:150-5, 1992.
101. Roy Chowdhury J, Roy Chowdhury N: Unveiling the mysteries of inherited disorders of bilirubion glucuronidation. Gastroenterology 104:, 1993.
102. Harding D, Jeremiah SJ, Povey S, Burchell B: Chromosomal mapping of a human phenol UDP-glucurononsyltransferase GNT-1. Ann Hum Genet 54:17-21, 1990.
103. McKusick VA: Discussion of Sleisenger MH, Kahn I, Barniville H, Rubin W, Ben-Ezzer J, Arias I. Non-hemolytic unconjugated hyperbilirubinemia with hepatic glucuronyl transferase deficiency: a genetic study in four generations. Trans Assoc Am Physicians 80:259-66, 1967.
104. Michaelsson M, Nosslin B, Sjolin S: Plasma bilirubin determination in the newborn infant. Pediatrics 35:925-31, 1965.
105. Stoll MS: Phototherapy of jaundice. In: Ostrow JD (ed). Bile pigments and jaundice: Molecular, metabolic and medical aspects. New York: Marcel Dekker, 551-80, 1986.
106. Callahan EW, Thaler M, Karon M, Bauer K, Schmid R: Phototherapy of severe unconjugated hyperbilirubinemia: formation and removal of labeled bilirubin derivatives. Pediatrics 46:841-8, 1970.
107. Gorodischer R, Levy G, Krasner J, Yaffe SJ: Congenital nonobstructive, nonhemolytic jaundice: effect of phototherapy. N Engl J Med 282:375-7, 1970.
108. Karon M, Imach D, Schwartz A: Effective phototherapy in congenital nonobstructive, nonhemolytic jaundice. N Engl J Med 282:377-80, 1970.
109. O'Reilly C, Dixon R: Crigler-Najjar syndrome: treatment at home with phototherapy. Scot Med J 33:335-6, 1988.
110. Billing BH: Intestinal and renal metabolism of bilirubin including enterohepatic circulation. In: Ostrow JD (ed). Bile pigments and jaundice. New York: Marcel Dekker, 255-69, 1986.
111. Poland RL, Odell GB: Physiologic jaundice: the enterohepatic circulation of bilirubin. N Engl J Med 284:1-6, 1971.
112. Amed P, Pratt A, Land VJ, Flye MW, Chaplin H: Multiple plasma exchanges successfully maintain a young adult patient with Crigler-Najjar syndrome type I. J Clin Apheresis 5:17-20, 1989.
113. Starzl TE, Iwatsuki S, Van Thiel DH, et al: Evolution of liver transplantation. Hepatology 2:614-36. 1982.
114. Wolff H, Otto G, Geist H: Liver transplantation in CriglerNajjar syndrome. A case report. Transplantation 42:84, 1986.
115. Kaufman SS, Wood RP, Shaw BW Jr, et al: Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology 6:1259-62, 1986.
116. Shevell MI, Bernard B, Adelson JW, Doody DP, Laberge J-M, Guttman FM. Crigler-Najjar syndrome type I: treatment by home phototherapy followed by orthotopic liver transplantation. J. Pediatr 110:429-31. 1987.
117. Mowat AP; Liver disorders in children: the indications for liver replacement in parenchymal and metabolic diseases. Transplant Proc 19:3236-41, 1987.
118. Scharschmidt BF, Martin JF, Shapiro LJ, Plotz PH, Berk PD: Hemoperfusion through albumin-conjugated agarose gel for the treatment of neonatal jaundice in Rhesus monkeys. J Lab Clin Med 89:101-9, 1977.
119. Scharschmidt BF, Plotz PH, Berk PD, Waggoner JG, Vergalla J: Removing substances from blood by affinity chromatography. II. Removing bilirubin from the blood of jaundiced rats by hemoperfusion. J Clin Invest 53:786-95, 1974.
120. Drummond GS, Kappas A: Prevention of neonatal hyperbilirubinemia by Sn protoporphyrin IX, a potent competitive inhibitor of heme oxidalion. Proc Natl Acad Sci USA 78:6466-70, 1981.
121. Drummond GS, Kappas A: Chemoprevention of neonatal jaundice: potency of tin protoporphyrin in an animal model. Science 217:1250-2, 1982.
122. Sassa S, Drummond GS, Bernstein SE, Kappas A: Tin-protoporphyrin suppression of hyperbilirubinemia in mutant mice with severe hemolytic anemia. Blood 61:1011-3, 1983.
123. Roy Chowdhury J, Portman OW, Roy Chowdhury N, Alexander M, Cornelius CE, Arias IM: Mechanism of fasting hyperbilirubinemia: studies in Bolivian squirrel monkeys. Hepatology 2:723, 1982.
124. Vreman HJ, Rogers PA, Stevenson DK: Zinc protoporphyrin administration supresses iatrogenic hemolytic bilirubin production in Rhesus neonates. J Pediatr 117:292-7, 1990.
125. Sisson TRC, Drummond GS, Samonte D, Calabio R, Kappas A: Sn-protoporphyrin blocks the increase in serum bilirubin levels that develops postnatally in homozygous Gunn rats. J Exp Med 167:1247-52, 1988.
126. Stevenson DK, Rogers PA, Vreman HJ: The use of metalloporphyrins for the chemoprevention of neonatal jaundice. Am J Dis Child 143:353-6, 1989.
127. Kappas A, Drummond GS, Manola T, Petmezaki A, Valaes T: Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics 81:485-97, 1988.
128. Hintz SR, Vreman HJ, Stevenson DK: Mortality of metalloporphyrin-treated neonatal rats after light exposure. Dev Pharmacol Ther 14:187-92, 1990.
129. Kapitulnik J, Ostrow JD: Pharmacologic modification of jaundice. In: Ostrow JD (ed). Bile pigments and jaundice. New York: Marcel Dekker, 539-49, 1986.
130. Kapitulnik J, Hardwick JP, Ostrow JD, Webster CC, Park SS, Gelboin HV: Increase in specific cytochrome P-450 isoenzyme in the liver of congenitally jaundice Gunn rats. Biochem J 242:297-300, 1987.
131. Kapitulnik J, Gonzalez FJ: A marked increase in P450IA1 and P450IA2 gene expression in congenitally jaundiced Gunn rats. J Hepatol 11:833, 1990.
132. Kapitulnik J, Ostrow JD: Stimulation of bilirubin catabolism in jaundiced Gunn rats by an inducer of microsomal mixed-function monooxygenases. Proc Natl Acad Sci USA 75:682-5, 1978.
133. De Matteis F, Trenti T, Gibbs AH, Grieg JB: Inducible bilirubin degrading system in the microsomal fraction of rat liver. Mol Pharmacol 35:831-8, 1989.
134. De Matteis F, Dawson SJ, Boobis AR, Comoglio A: Inducible bilirubin degrading system of rat liver microsomes: role of cytochrome P450 IA1. Mol Pharmacol 40:686-91, 1991.
135. Wattenberg LW, Loub WD: Inhibition of polycyclic aromatic hydrocarbon-inducible neoplasia by naturally occuring indoles. Cancer Res 38:1410-3, 1978.
136. Pantuck EJ, Pantuck CB, Garland WA, et al: Stimulatory effect of brussel sprouts and cabbage on human drug metabolism. Clin Pharmacol Ther 25:88-95, 1979.
137. Rugstad HE, Robinson SH, Yanoni C, Tashjian AH Jr: Transfer of bilirubin uridine-5-diphosphate-glucuronyltransferase to enzyme deficient rats. Science 170:553-5, 1970.
138. Matas AJ, Sutherland DER, Steffes MW, et al: Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats. Science 192:892-4, 1976.
139. Groth GG, Alborgh B, Bjorken C, Sundberg B, Lundgren G: Correction of hyperbilirubinemia in glucuronyltransferase-deficient rats by intraportal hepatocyte transplantation. Transpl Proc 9:313-6, 1977.
140. Gupta S, Roy Chowdhury J: Hepatocyte transplantation: back to the future. Hepatology 15:156-61, 1992.
141. Vroemen JPAM, Blanckaert N, Buurman WA, Heirwegh KPM, Koostra G: Treatment of enzyme deficiency by hepatocyte transplantation in rats. J Surg Res 39:267-75, 1985.
142. Vroemen JPAM, Buurman WA, Heirwegh KPM, Van der Linden C, Koostra G: Hepatocyte transplantation for enzyme deficiency disease incongeneic rats. Transplantation 42:130-5, 1986.
143. Demetriou AA, Whiting JF, Feldman D, el al: Replacement of liver function in rats by transplantation of microcarrier attached hepatocytes. Science 233:1190-2, 1986.
144. Bruni S, Chang TMS: Hepatocytes immobilized by microencapsulation in artificial cells: effects on hyperbilirubinemia in Gunn rats. Biomater Artif Cells Artif Organs 17:403-11, 1989.
145. Dixit V, Darvasi R, Arthur M, Brezina M, Lewin K, Gitnick G: Restoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytes. Hepatology 12:1342-9, 1990.
146. Gupta S, Aragona E, Vemuru RP, Bhargava K, Burk RD, Roy Chowdhury J: Permanent function and engraftment of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation. Hepatology 14:142-9, 1991.
147. Makowka L, Lee G, Coboum CS, Farber E, Falk JA, Falk RE: Allogeneic hepatocyte transplantation in the rat spleen under cyclosporine immunosuppression. Transplantation 42:537-41, 1986.
148. Ledley FD, Darlington GJ, Hahn T, Woo SLC: Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions. Proc Natl Acad Sci USA 84:5335-9, 1987.
149. Wilson JM, Jefferson DM, Roy Chowdhury J, Novikoff PM, Johnston DM, Mulligan RC: Retrovirus-mediated transduction of adult hepatocytes. Proc Natl Acad Sci USA 85:3014-8, 1988.
150. Anderson KD, Thompson JA, DiPietro JM, Montgomery KT, Reid LM, Anderson WF: Gene expression in implanted rat hepatocytes following retroviral-mediated gene transfer. Somatic Cell Mol Genet 15:215-27, 1989.
151. Kaleco M, Garcia JV, Miller AD: Persistent gene expression after retroviral gene transfer into liver cells in vivo. Hum Gene Ther 2:27-32, 1991.
152. Wu CH, Wilson JM, Wu CY: Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J Biol Chem 264:16985-7, 1989.
153. Gilbert A, Lereboullet P: La cholemie simple familiale. Semin Med 1901; 21:241-5.
154. Gilbert A, Lereboullet P, Herscher M: Les trois cholemies congenitales. Bull Mem Soc Med Hop Paris 24:1203-10, 1907.
155. Chauffard A: Pathogene de l'ictere congenital d l'adulte. Semin Med 27:25-7, 1907.
156. Minkowski M: Ictere chronique hereditaire avec splenomegalie. Semin Med 20:149, 1900.
157. Berk PD, Bloomer JR, Howe RB, Berlin NI: Constitutional hepatic dysfunction (Gilbert's syndrome): a new definition based on kinetic studies with unconjugated radiobilirubin. Am J Med 49:296-305, 1970.
158. Foulk WT, Butt HR, Owen CA, Whitcomb FF: Constitutional hepatic dysfunction (Gilbert's disease): its natural history and related syndromes. Medicine 38:25-46, 1959.
159. Arias IM: Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults. J Clin Invest 41:2233-45, 1962.
160. Berk PD: The distribution of serum bilirubin levels in man: implications for the diagnosis of Gilbert's syndrome. In: Okolicsanyi L (ed). Familial hyperbilirubinemia. New York: John Wiley, 7-19, 1980.
161. Felsher BF, Rickard D, Redeker AG: The reciprocal relation between caloric intake and the degree of hyperbilirubinemia in Gilbert's syndrome. N Engl J Med 283:170-2, 1970.
162. Blaschke TF, Berk PD, Rodkey FL, Scharschmidt BF, Collison HA, Waggoner JG: Drugs and the liver. 1. Effects of glutethimide and phenobarbital on hepatic bilirubin clearance, plasma bilirubin turnover, and carbon monoxide production in man. Biochem Pharmacol 23:2795-806, 1974.
163. Black M, Sherlock S: Treatment of Gilbert's syndrome with phenobarbitone. Lancet 1:1359-62, 1970.
164. Hunter JO, Thompson RPH, Rake MO, Williams R: Controlled trial of phetharbital, a non-hypnotic barbiturate, in unconjugated hyperbilirubinemia. Br Med J 2:497-9, 1971.
165. Thompson RPH, Pilcher CWT, Robinson J, Strathers GM, McLean AEM, Williams R: Treatment of unconjugated jaundice with dicophane. Lancet 2:4-6, 1969.
166. Powell LW, Hemingway E, Billing BH, Sherlock S: Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome): a study of 42 families. N Engl J Med 277:1108-12, 1967.
167. Bailey A, Robinson D, Dawson AM: Does Gilbert's disease exist? Lancet 1:931-3, 1977.
168. Yamaguchi K, Okuda K, Yanemitsu H, Tsukada Y, Shigata H: Cyclic premenstrual unconjugated hyperbilirubinemia. Report of two cases. Ann Intern Med 83:514-7, 1975.
169. Olsson R, Bliding A, Jagenburg R, et al: Gilbert's syndrome - does it exist? A study of the prevalence of symptoms in Golbert's syndrome. Acta Med Scand 224:485-90, 1988.
170. Okolicsanyi L, Fevery J, Billing BH, et al: How should mild, isolated unconjugated hyperbilirubinemia be investigated? Semin Liver Dis 3:65-72, 1983.
171. McColl KE, Thompson GG, Omar E, Moore MR, Goldberg A: Porphyrin metabolism and haem biosynthesis in Gilbert's syndrome. Gut 28:125-30, 1987.
172. Moore MR, McColl KEL, Rimington C, Goldberg A: Disorders of porphyrin metabolism. New York: Plenum Press, 94-5, 1987.
173. Frank M, Doss MO: Relevance of urinary coproporphyrin isomers in hereditary hyperbilirubinemias. Clin Biochem 22:221-2, 1989.
174. Earth RF, Grimley PM, Berk PD, Bloomer JR, Howe RB: Excess lipofuscin accumulation in constitutional hepatic dysfunction (Gilbert's syndrome). Arch Pathol 91:41-7, 1971.
175. Auclair C, Feldmann G, Hakim J, Boivin P, Troube H, Boucherot J: Bilirubin and paranitrophenol glucuronyl transferase activities and ultrastructural aspects of the liver in patients with chronic hemolytic anemias. Biomedicine 25:61-5, 1976.
176. Jezequel AM, Mosca PG, Koch MM, Orlandi F: The fine morphometry of unconjugated hyperbilirubinemia revisited with stereometry. In: Okolicsanyi L (ed). Familial hyperbilirubinemia. New York: John Wiley, 69-70, 1980.
177. McGee JOD. Allan JB, Russell RI, Patrick RS: Liver ultrastructure in Gilbert's syndrome. Gut 16:220-4, 1975.
178. Dawson J, Carr-Locke DL, Talbot IC, Rosenthal FD: Gilbert's ndrome: evidence of morphological heterogeneity. Gut 20:848-53, 1979.
179. Dawson J, Seymour CA, Peters TJ: Gilbert's syndrome. Analytical subcellular fractionation of liver biopsy specimens. Clin Sci 57:491-7, 1979.
180. Billing BH, Williams R, Richards TG: Defects in hepatic transport of bilirubin in congenital hyperbilirubinemia: an analysis of plasma bilirubin disappearance curves. Clin Sci 27:245-57, 1964.
181. Ventura E, Zeneroli ML, Rocchi E, et al: Crystalline bilirubin kinetics in Gilbert's syndrome: a multi-center study. In: Okolicsanyi L (ed). Familial hyperbilirubinemia. New York: John Wiley, 109-19, 1980.
182. 3 kinetic studies: pattern of normals, Gilbert's syndrome and hemolytic state. Acta Hepato-Gastroenterol 20:363-71, 1973.
183. Berk PD, Howe RB, Bloomer JR, Berlin NI: Studies of bilirubin kinetics in normal adults. J Clin Invest 48:2176-90, 1969.
184. Fleischner G, Kamisaka K, Habig W, Jacoby W, Arias IM: Human ligandin: characterization and quantitation. Gastroenterology 69:821, 1975.
185. Felsher BF, Craig JR, Carpio N: Hepatic bilirubin glucuronidation in Gilbert's syndrome. J Lab Clin Med 81:829-37, 1973.
186. Black M, Billing BH: Hepatic bilirubin UDP glucuronyl transferase activity in liver disease and Gilbert's syndrome. N Engl J Med 280:1266-71, 1969.
187. Auclair C, Hakim J, Boivin P, Troube H, Boucherrot J: Bilirubin and paranitrophenol glucuronyl transferase activity of the liver in patients with Gilbert's syndrome. Enzyme 21:97-107, 1976.
188. Goresky CA, Gordon ER, Shaffer EA, Par EP, Carassavas D, Aronoff A: Definition of a conjugation dysfunction in Gilbert's syndrome: studies of the handling of bilirubin loads and of the pattern of bilirubin conjugates secreted in bile. Clin Sci Mol Med 55:63-71, 1978.
189. Fevery J, Van Damme B, Michiels R, De Groots J, Heirwegh KPM: Bilirubin
190. Adachi Y, Yamashita M, Nanno T, Yamamoto T: Proportion of conjugated bilirubin in bile in relation to hepatic bilirubin UDP-glucuronyltransferase activity. Clin Biochem 23:131-4, 1990.
191. Muraca M, Fevery J, Blanckaert N: Relationships between serum bilirubins and production and conjugation of bilirubin: studies in Gilbert's syndrome, Crigler-Najjar disease, hemolytic disorders and rat models. Gastroenterology 92:309-17, 1987.
192. Adachi Y, Katoh H, Fuchi I, Yamamoto T: Serum bilirubin fractions in healthy subjects and patients with unconjugated hyperbilirubinemia. Clin Biochem 23:247-51, 1990.
193. Gordon ER, Goresky CA: A rapid and quantitative high performance liquid Chromatographic method for assaying bilirubin and its conjugates in bile. Can J Biochem 60:1050-7, 1982.
194. Gordon ER, Goresky CA: The formation of bilirubin diglucuronide by rat liver microsomal preparations. Can J Biochem 58:1302-10, 1980.
195. Blanckaert N, Gollan JL, Schmid R: Bilirubin diglucuronide synthesis by a UDP-glucuronic acid-dependent enzyme system in rat liver microsomes. Proc Natl Acad Sci USA 76:2037-41, 1979.
196. Berry CS, Hallinan T, Billing BH: The kinetics of hepatic bilirubin monoglucuronide formation in needle biopsy specimens from patients with hyperbilirubinemia. In: Preisig R, Bircher J (eds). The liver: Quantitative aspects of structure and function. Vol. 3. Aulendorf, Germany: Cantor, 226-32, 1979.
197. Leyten R, Vroemen JAPM, Blanckaert N, Heirwegh KPM: The congenic normal R/APfd and jaundiced R/APfd-/j/j rat strains: a new animal model of hereditary non-haemolytic unconjugated hyperbilirubinemia due to defective bilirubin conjugation. Lab Anim 20:335-42, 1986.
198. Kirshenbaum G, Shames DM, Schmid R: An expanded model of bilirubin kinetics: effect of feeding, fasting, and phenobarbital in Gilbert's syndrome. J Pharmacol Biopharmacol 2:115-55, 1976.
199. 14C) bilirubin clearance in patients with unconjugated hyperbilirubinemia. Clin Sci Mol Med 46:1-17, 1974.
200. Black M, Perret RD, Carter AE: Hepatic bilirubin UDP-glucuronyl transferase activity and cytochrome P-450 content in a surgical population and the effects of preoperative drug therapy. J Lab Clin Med 81:704-12, 1973.
201. Ohkubo H, Okuda K, Iida S: Effects of corticosteroids on bilirubin metabolism in patients with Gilbert's syndrome. Hepatology 1:168-72, 1981.
202. Tavoloni N, Wittman R, Jones MJT, Berk PD: Effect of low dose phenobarbital on hepatic microsomal UDP-glucuronyl transferase activity. Biochem Pharmacol 32:2143-7, 1983.
203. Berk PD, Berman MD, Blitzer BL, et al: Effect of splenectomy on hepatic bilirubin clearance in patient with hereditary spherocytosis: implications for the diagnosis of Gilbert's syndrome. J Lab Clin Med 98:37-45, 1981.
204. Forker EL, Luxon B: Hepatic transport kinetics and plasma disappearance curves: distributed modeling versus conventional approach. Am J Physiol 235:E648-69, 1978.
205. Berk PD, Blaschke TF, Waggoner JG: Defective BSP clearance in patients with constitutional hepatic dysfunction (Gilbert's syndrome). Gastroenterology 63:472-81, 1972.
206. Ohkubo H, Okuda K, Iida S: A constitutional unconjugated hyperbilirubinemia combined with indocyanine green intolerance: a new functional disorder? Hepatology 1:319-24, 1981.
207. Martin JF, Vierling JM, Wolkoff AW, Scharschmidt BF, Vergalla J, Waggoner JG: Abnormal hepatic transport of indocyanine green in Gilbert's syndrome. Gastroenterology 70:385-91, 1976.
208. Gentile S, Persico M, Tiribelli C: Abnormal hepatic uptake of low doses of sulfobromophthalein in Gilbert's syndrome. Hepatology 12:213-7, 1990.
209. Douglas JG, Beckett JG, Nimmo IA, Finlayson NDC, PercyRobb IW: Bile salt measurements in Gilbert's syndrome. Eur J Clin Invest 11:421-3, 1981.
210. Vierling JM, Berk PD, Hofmann AF, Martin JF, Wolkoff AW, Scharschmidt BF: Normal fasting-state levels of serum cholyl conjugated bile acids in Gilbert's syndrome: an aid to the diagnosis. Hepatology 2:340-3, 1982.
211. Roda A, Roda E, Sama C, et al: Serum primary bile acids in Gilbert's syndrome. Gastroenterology 82:77-83, 1978.
212. Ohkubo H, Okuda K, lida S, Makino I: Ursodeoxycholic acid oral tolerance test in patients with constitutional hyperbilirubinemias and effect of phenobarbital. Gastroenterology 81:126-35, 1981.
213. Kawasaki H, Yasuhito Y, Kishimoto Y, et al: Abnormality of oral ursodeoxycholic acid tolerance test in the Dubin-Johnson syndrome. Clin Chim Acta 112:13-9, 1981.
214. Bircher J: Investigation of drug metabolism in Gilbert's syndrome. In: Okolicsanyi L (ed). Familial hyperbilirubinemia. New York: John Wiley, 171-3, 1980.
215. Reichen J: Congenital unconjugated hyperbilirubinemia syndromes. Semin Liver Dis 3:24-35, 1983.
216. Posner J, Cohen AF, Land G, Winton C, Peck AW: The pharmacokinetics of lamotrigine (BW430C) in healthy subjects with unconjugated hyperbilirubinemia. Br J Clin Pharmacol 28:117-20, 1989.
217. Schmid R, Hammaker L: Glucuronide formation in patients with constitutional hepatic dysfunction (Gilbert's syndrome). N Engl J Med 260:1310-4, 1959.
218. Ullrich D, Sieg A, Blume R, Bock KW, Schroter W, Bircher J: Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome. Eur J Clin Invest 17:237-40, 1987.
219. Douglas AP, Savage RL, Rawlins MD: Paracetamol (acetaminophen) kinetics in patients with Gilbert's syndrome. Eur J Clin Pharmacol 13:209-12, 1978.
220. Platzer R, Kuepfer A, Bircher J, Preisig R: Polymorphic acetylation and aminopyrine demethylation in Gilbert's syndrome. Eur J Clin Invest 8:219-23, 1978.
221. Siegmund W, Fengler JD, Franke G, et al: N-acetylation and debrisoquine hydroxylation polymoprphisms in patients with Gilbert's syndrome. Br J Clin Pharmacol 32:467-72, 1991.
222. Carulli N, Ponz de Leon M, Mauro E, Manenti F, Ferrari A: Alteration of drug metabolism in Gilbert's syndrome. Gut 17:581-7, 1976.
223. Frezza M, Pozzato G, Quaranta C, Tiribelli C, Ferari A: Abnormality in the hepatic transport of rifamycin SV in Gilbert's syndrome. Ital J Gastroenterol 12:1-5, 1980.
224. Powell LW, Billing BH, Williams HS: An assessment of red cell survival idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome) by the use of radioactive diisopropylfluorophosphate and chromium. Aust Ann Med 16:221-5, 1967.
225. Berlin NI, Berk PD: Quantitative aspects of bilirubin metabolism for hematologists. Blood 57:983-99, 1986.
226. Berk PD, Bloomer JR, Howe RB, Blaschke TF, Berlin NI: Bilirubin production as a measure of red cell life span. J Lab Clin Med 79:364-78, 1972.
227. Tarao K, Fukushima K, Endo O, Kamiyo A: The effects of acute infectious hepatitis and cirrhosis of the liver on the nonerythropoietic component of early bilirubin. J Lab Clin Med 87:240-50, 1976.
228. Fevery J, Verwilghen R. Tan TG, DeGroote J: Glucuronidation of bilirubin and the occurrence of pigment gallstones in patients with chronic hemolytic diseases. Eur J Clin Invest 10:219-26, 1980.
229. Maddrey SC, Cukier JO, Magalang AC, Boitnott JH, Odell GB: Hepatic bilirubin-UDP-glucuronyltransferase in patients with sickle cell anemia. Gastroenterology 74:193-5, 1978.
230. Kornberg A: Latent liver disease in persons recovered from catarrhal jaundice and in otherwise normal medical students as revealed by the bilirubin excretion test. J Clin Invest 21:299-308, 1942.
231. Alwall N, Laurell CB, Nilsby I: Studies on heredity in cases of nonhemolytic bilirubinemia without direct van den Bergh reac-tion. Acta Med Scand 124:114-25, 1946.
232. Vaughan JM, Haslewood GAD: The normal level of plasma bilirubin. Lancet 1:133-5, 1938.
233. Werner M, Tolls RE, Hultin JV, et al: Influence of sex and age on the normal range of eleven serum constituents. Z Kin Chem Klin Biochem 11:105-15, 1970.
234. Wilding P, Rollason JG, Robinson D: Patterns of change for various biochemical constituents detected in well population screening. Clin Chim Acta 41:375-87, 1972.
235. Owens D, Evans J: Population studies on Gilbert's syndrome. J Med Genet 12:152-6, 1975.
236. Rosenthal P, Pincus M, Fink D: Sex- and age-related differences in bilirubin concentrations in serum. Clin Chem 30:1380-2, 1984.
237. Sieg A, Arab L, Schlierf G, et al: Die Pravalenz de GilbertSyndroms in Deutschland. Dtsch Med Wochenschr 112:1206-8, 1987.
238. Okolicsanyi L, Nassuato G, Muraca M, et al: Epidemiology of unconjugated hyperbilirubinemia: revisited. Semin Liver Dis 8:179-82, 1988.
239. Berk PD: Unresolved problems in the study of Gilbert's syndrome as a genetic entity distinct from the normal population. In: Preisig R, Bircher J (eds). The liver: Quantitative aspects of structure and function. Aulendorf, Germany: Cantor, 217-25, 1979.
240. Peel ALLG, Ritchie HD: Gilbert's syndrome in patients with gall bladder stones. Ann R Coll Surg Engl 55:184-9, 1974.
241. Haff RC, Andrassy RJ, LeGrand DR, Rattner IA: Gallbladder disease in the young male. Am J Surg 131:232-4, 1976.
242. Henne-Bruns D, Kremer B: Manifestations eines Gilbert-Syndroms (Morbus Meulengracht) nach orthotoper Lebertransplantation: Seltene Ursache einer postoperativen Hyperbilirubinemie. Klin Wochenschr 66:596-8, 1988.
243. Graham JR: Gilbert's syndrome in identical twins. Med J Aust 147:524, 1987.
244. Gollan JL, Huang SN, Billing BH, Sherlock S: Prolonged survival in three brothers with severe type 2 Crigler-Najjar syn-drome: ultrastructural and metabolic studies. Gastroenterology 68:1543-55, 1975.
245. Hunter JO, Thompson RPH, Dunn PM, Williams R: Inheritance of type II Crigler-Najjar hyperbilirubinemia. Gut 14:46-9, 1973.
246. Labrune P, Myara A, Hennion C, Gout JP, Trivin F, Odievre M: Crigler-Najjar type II disease inheritance: a family study. J Inherited Metab Dis 12:302-6, 1989.
247. Penner E, Mayr WR, Pacher M, Djawan S, Seyfried H, Pantucek F: Gilbert's syndrome and HL-A. Preliminary report. Z Immunol Forsch Bedeinst 150:90-2, 1975.
248. Gilbert A, Herscher M: Sur le variations de la cholemie physiologique. Presse Med 14:209-11, 1906.
249. Barrett PVD: Hyperbilirubinemia of fasting. JAMA 217:1349-53, 1971.
250. Bloomer JR, Barrett PV, Rodkey FL, Berlin NI: Studies on the mechanism of fasting hyperbilirubinemia. Gastroenterology 61:479-87, 1971.
251. Davidson AR, Rojas-Bueno A, Thompson RPH, Williams R: Reduced caloric intake and nicotinic acid provocation tests in diagnosis of Gilbert's syndrome. Br Med J 2:480, 1975.
252. Felsher BR, Carpio NM: Caloric intake and unconjugated hyperbilirubinemia. Gastroenterology 69:42-7, 1975.
253. Owens D, Sherlock S: Diagnosis of Gilbert's syndrome: role of reduced caloric intake test. Br Med J 3:559-63, 1973.
254. 14C] bilirubin metabolism in normal subjects and patients with compensated cirrhosis. Clin Sci Mol Med 52:555-70, 1977.
255. Olsson R, Lindstedt G: Evaluation of tests for Gilbert's syndrome. Acta Med Scand 207:425-8, 1980.
256. Thomsen HF, Hardt F, Juhl E: Diagnosis of Gilbert's syndrome. Reliability of the caloric restriction and phenobarbital stimulation test. Scand J Gastroenterol 16:699-703, 1981.
257. Whitmer DI, Gollan JL: Mechanisms and significance of fasting and dietary hyperbilirubinemia. Semin Liver Dis 3:42-51, 1983.
258. Gollan JL, Hatt KJ, Billing BH: The influence of diet on unconjugated hyperbilirubinemia in the Gunn Rat. Clin Sci Mol Med 49:229-35, 1975.
259. Gronwall R, Mia AS: Fasting hyperbilirubinemia in horses. Dig Dis 17:473-6, 1972.
260. Cornelius CA: Congenital hyperbilirubinemias in selected domestic and wild animal species. In: Tavoloni N, Berk PD (eds). Hepatic transport and bile secretion: Physiology and pathophysiology. New York: Raven Press, 733-47, 1993.
261. Duvaldestin P, Mahu J-L, Berthelot P: Effect of fasting on substrate specificity of rat liver UDP-glucuronyltransferase. Biochim Biophys Acta 384:81-6, 1975.
262. Felsher BF, Carpio NM, VanCouvering K: Effect of fasting and phenobarbital on hepatic UDP-glucuronic acid formation in the rat. J Lab Clin Med 93:414-27, 1979.
263. Cowan RE, Thompson RPH, Kaye JP, Clark GM: The association between fasting hyperbilirubinemia and serum non-esterified fatty acids in man. Clin Sci Mol Med 53:155-63, 1977.
264. Gollan JL, Hole DR, Billing BH: The role of dietary lipid in the regulation of unconjugated hyperbilirubinemia in Gunn rats. Clin Sci 57:327-37, 1979.
265. Orzes N, Tamaro G, Parco S, et al: Serum free fatty acids and bilirubin concentration during fasting in patients with Gilbert's syndrome and normal controls. Ric Clin Lab 17:61-6, 1987.
266. Laperche Y, Preaux A-M, Feldmann G, et al: Effect of fasting on organic anion uptake by isolated rat liver cells. Hepatology 1:617-21, 1981.
267. Stein LB, Mishkin S, Fleischner G, Gatmaitan Z, Arias IM: Effect of fasting on hepatic ligandin, Z protein, and organic anion transfer from plasma in rats. Am J Physiol 231:1371-6, 1976.
268. Scharschmidt BF, Waggoner JG, Berk PD: Hepatic organic anion uptake in the rat. J Clin Invest 56:1280-92, 1975.
269. Bakken AF, Thaler MM, Schmid R: Metabolic regulation of heme catabolism and bilirubin production. I. Hormonal control of hepatic heme oxygenase activity. J Clin Invest 51:530-6, 1972.
270. Barrett PV: Effect of caloric and noncaloric materials in fasting hyperbilirubinemia. Gastroenterology 68:351-60, 1975.
271. Bensinger TA, Maisels MJ, Carlson DE, Conrad ME: Effect of low calorie diet on endogenous carbon monoxide production: normal adults and Gilbert's syndrome. Proc Soc Exp Biol Med 144:417-9, 1973.
272. Kutz K, Egger G, Bachofen H, Preisig R: Effect of fasting on endogenous carbon monoxide production in normal subjects and those with constitutional hepatic dysfunction (Gilbert's syndrome). In: Berk PD, Berlin NI (eds). The chemistry and physiology of bile pigments. Washington, DC: U.S. Government Printing Office, 156-67, 1977.
273. Felsher BF: Effect of changes in dietary components on the serum bilirubin in Gilbert's syndrome. Am J Clin Nutr 29:705-9, 1976.
274. Gollan JL, Bateman C, Billing BH: Effect of dietary composition of the unconjugated hyperbilirubinemia of Gilbert's syndrome. Gut 16:335-46, 1976.
275. Jesurun CA, Ostea EM: Elevated bilirubin and albumin saturation in breast fed infants: role of supplemental feedings. Pediatr Res 13:497, 1979.
276. Woolley MM, Felsher BF, Carpio M, Isaacs H: Jaundice, hypertrophic pyloric stenosis and hepatic glucuronyl transferase. J Pediatr Surg 9:359-63, 1974.
277. Fevery J, Heirwegh JP, DeGroote J: Unconjugated hyperbilirubinemia in achalasia. Gut 15:121-4, 1974.
278. Fromke VL, Miller D: Constitutional hepatic dysfunction (CHD: Gilbert's disease): a review with special reference to a characteristic increase and prolongation of the hyperbilirubinemic response to nicotinic acid. Medicine 51:451-64, 1972.
279. Rollinghoff W, Paumgartner G, Preisig R: Nicotinic acid test in the diagnosis of Gilbert's syndrome - correlation with bilirubin clearance. Gut 22:663-8, 1981.
280. Ohkubo H, Musha H, Okuda K: Studies on nicotinic acid interaction with bilirubin metabolism. Dig Dis 24:700-4, 1979.
281. Gentile S, Marmo R, Persico M, Faccenda F, Orlando C, Rubba P: Dissociation between vascular and metabolic effects of nicotinic acid in Gilbert's syndrome. Clin Physiol 10:171-8, 1990.
282. Gentile S, Gentile F: Hypersideremic and hyperbilirubinemic effect of nicotinic acid in patients with Gilbert's syndrome. Hepato-Gastroenterology 34:152-4, 1987.
283. Frezza M, Chiesa L, Zaramella MG, et al: Unconjugated hyperbilirubinemia in HBV carriers. Discriminant value of nicotinic acid (NA) test. Scand J Clin Lab Invest 47:63-7, 1987.
284. Dickey W, McAleer JJ, Calender ME: The nicotinic acid provocation test and unconjugated hyperbilirubinemia. Ulster Med J 60:49-52, 1991.
285. Gentile S, Del Vecchio Blanco C, Persico M, Marmo R, Coltorti M: Familial clustering of heterogeneous chronic unconjugated hyperbilirubinemia. Hepato-Gastroenterology 33:155-8, 1986.
286. Micheli F, Dominici G: Recherches sur une forme d'ictere helytique congenital et familial avec bilirubinemie atypique. Sangre 6:953-61, 1932.
287. Crigler JF Jr, Gold NI: Effect of sodium phenobarbital on bilirubin metabolism in an infant with congenital nonhemolytic unconjugated hyperbilirubinemia and kernicterus. J Clin Invest 48:42-55, 1969.
288. Kreek MJ, Sleisenger MH: Reduction of serum-unconjugated bilirubin with phenobarbitone in adult congenital nonhemolytic unconjugated hyperbilirubinemia. Lancet 2:73-8, 1968.
289. Yaffe SJ, Levy G, Matsuzawa T, Baliah T: Enhancement of glucuronide-conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. N Engl J Med 275:1461-6, 1966.
290. Berk PD, Javitt N: Hyperbilirubinemia and cholestasis. North Am J Med 64:311-26, 1978.